Почетна › Глиобластом › Калифорнија
Клинички испитувања за Глиобластом во Калифорнија
40 студии за Глиобластом бараат учесници на локации во Калифорнија.
Градови во Калифорнија
- Los Angeles23 студии
- San Francisco17 студии
- Baldwin Park10 студии
- San Diego7 студии
- Mountain View5 студии
- Sacramento4 студии
- Orange4 студии
- Irvine4 студии
Официјален текст на студијата (англиски)
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
- City of Hope Comprehensive Cancer Center, Duarte
- UC San Diego Moores Cancer Center, La Jolla
- Los Angeles General Medical Center, Los Angeles
- и уште 2
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT05432804A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
- University of California, San Diego, La Jolla
- Cedars Sinai - Samuel Oschin Comprehensive Cancer Institute, Los Angeles
- St. Joseph Hospital, Orange
Се регрутираФаза 2/3
Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT03970447Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
- Kaiser Permanente, Los Angeles
- UCLA, Los Angeles
- Sutter Health - California Pacific Medical Center, San Francisco
- и уште 1
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 29.9.2026 · NCT05902169Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- UCSD Moores Cancer Center, La Jolla
- Cedars-Sinai Medical Center, Los Angeles
- Stanford University, Palo Alto
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07326566A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
- University of California San Diego, San Diego
- University of California San Francisco, San Francisco
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT05303467Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma
- University of California Davis Comprehensive Cancer Center, Sacramento
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07145112A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Children's Hospital Los Angeles, Los Angeles
- University of California at Los Angeles, Los Angeles
Се регрутираФаза 1/2
До возраст 25 · Сите полови · Ажурирано 25.9.2026 · NCT04094610Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- Precision NextGen Oncology, Beverly Hills
- OPN Healthcare, Inc, Glendale
- University of Southern California, Los Angeles
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 24.9.2026 · NCT06047379Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
- Cedars-Sinai Medical Center, Los Angeles
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 21.9.2026 · NCT04977375ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 18.9.2026 · NCT07089641Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- USC / Norris Comprehensive Cancer Center, Los Angeles
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
- и уште 1
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 10.9.2026 · NCT07452458A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
- City of Hope - Duarte Cancer Center, Duarte
- UCLA Health Bowyer Oncology Center, Los Angeles
- UCSF Helen Diller Medical Center at Parnassus Heights - Neurology, San Francisco
- и уште 1
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 10.9.2026 · NCT06914128Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma
- University of California, Los Angeles (Data Collection Only), Los Angeles
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 9.9.2026 · NCT06934889Multiple Intracerebral Doses of Neural Stem Cell-Based Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas
- City of Hope Medical Center, Duarte
- Standford University, Stanford
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 9.9.2026 · NCT05139056Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
- City of Hope Comprehensive Cancer Center, Duarte
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- UC San Diego Moores Cancer Center, La Jolla
- и уште 2
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 2.9.2026 · NCT06860594SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- University of California San Diego, La Jolla
- University of California, Los Angeles, Los Angeles
- Hoag Memorial Hospital Presbyterian, Newport Beach
- и уште 2
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 28.8.2026 · NCT05303519Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial
- Cedars-Sinai Medical Center, Los Angeles
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 18.8.2026 · NCT06319027Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells
- University of California, San Francisco, San Francisco
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 13.8.2026 · NCT06186401Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade Gliomas
- City of Hope Medical Center, Duarte
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 12.8.2026 · NCT07544992A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment
- Cedars-Sinai Medical Center, Los Angeles
- University of California, San Francisco, San Francisco
- Pacific Neuroscience Institute / Saint John's Cancer Institute, Santa Monica
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 5.8.2026 · NCT05708352A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial
- University of California, San Francisco, San Francisco
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 31.7.2026 · NCT06069726DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
- City of Hope, Duarte
- HOAG, Newport Beach
- UCSF, San Francisco
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 1.7.2026 · NCT06805305Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma
- City of Hope Medical Center, Duarte
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 29.6.2026 · NCT06815029Investigating the Feasibility and Acceptability of an Innovative Interdisciplinary Supportive Care Program: Couples Coping Together Against Cancer
- City of Hope Medical Center, Duarte
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
Возраст 18 и постари · Сите полови · Ажурирано 24.6.2026 · NCT07664579A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
- University of California, Los Angeles (UCLA) Department of Medicine - Hematology/Oncology, Los Angeles
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 23.6.2026 · NCT04678648ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
- University of California, San Francisco, San Francisco
Се регрутираФаза 1
Возраст од 2 до 21 · Сите полови · Ажурирано 11.6.2026 · NCT04732065PH Sensitive MRI Based Resections of Glioblastoma
- Ronald Reagan Medical Center, Los Angeles
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 4.5.2026 · NCT06176066Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- Beckman Research Institute of City of Hope, Duarte
- VA Medical Center, Fresno, Fresno
- Santa Clara Valley Medical Center, Fruitdale
- и уште 5
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 30.4.2026 · NCT05297734Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- University of California, Irvine, Irvine
- University of California Los Angeles, Los Angeles
- University of California at San Francisco, San Francisco
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 13.4.2026 · NCT06810544Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma Patients
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 10.3.2026 · NCT07461948Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 10.11.2025 · NCT06090903SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Duarte
- Massive Bio SYNERGY-AI site, Irvine
- Massive Bio SYNERGY-AI site, La Jolla
- и уште 3
Се регрутираНабљудувачка студија
Сите возрасти · Сите полови · Ажурирано 28.10.2025 · NCT03452774Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells
- University of California at Los Angeles, Los Angeles
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 8.10.2025 · NCT06059690A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
- Cedars Sinai Medical Center, Los Angeles
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 24.9.2025 · NCT05941507APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute, Los Angeles
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 27.6.2025 · NCT03175224The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
- University of California, San Francisco, San Francisco
Се регрутираНабљудувачка студија
Возраст од 18 до 90 · Сите полови · Ажурирано 28.2.2024 · NCT06283927The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
- University of California, San Francisco, San Francisco
Се регрутираНабљудувачка студија
До возраст 90 · Сите полови · Ажурирано 22.2.2024 · NCT06273176The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
- University of California, San Francisco (UCSF), San Francisco
Се регрутираНабљудувачка студија
Возраст од 18 до 90 · Сите полови · Ажурирано 22.2.2024 · NCT06118723The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
- University of California, San Francisco, San Francisco
Се регрутираНабљудувачка студија
Возраст од 18 до 90 · Сите полови · Ажурирано 27.11.2023 · NCT06146738The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
- University of California, San Francisco, San Francisco
Се регрутираНабљудувачка студија
Возраст од 18 до 90 · Сите полови · Ажурирано 27.11.2023 · NCT06146725Од ClinicalTrials.gov, податоци преземени 5.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.